Anxiety Disorders Practice Test

In older adults, responses to benzodiazepines change and the risks rise, so they require careful handling rather than standard dosing. Aging alters how the body processes and responds to these drugs: there’s often increased sensitivity to their sedative and cognitive effects, and the body clears the medication more slowly. This means even small doses can cause pronounced drowsiness, slowed thinking, and memory problems. The consequences you most need to watch for are delirium, confusion, impaired coordination, and a higher risk of falls and fractures. Long daytime sedation can also interfere with functioning and increase hospital safety concerns. Because some benzodiazepines have active metabolites that linger, especially in longer-acting options, the medication can accumulate and prolong effects in the elderly. Guidance to reduce harm is to use the lowest effective dose for the shortest possible period, and to favor alternatives when possible. If a benzodiazepine is considered necessary, opt for the shortest-acting agent and monitor closely for cognitive changes, sedation, and balance issues. Emphasize nonpharmacologic approaches first (like sleep hygiene or cognitive-behavioral therapy for anxiety) and consider nonbenzodiazepine options when appropriate, always with a plan to taper and discontinue as feasible. This helps explain why standard dosing isn’t appropriate for older adults and why cautious use with a bias toward alternatives is the recommended approach.